Toffalori et al. analyzed a similar population of relapsed AML patients after alloHSCT by performing gene expression profiles of AML blasts purified from patients at serial time points and found that class II downregulation was a mechanism of relapse in AML related to defective CIITA. The gene discussed is CIITA; the disease is acute myeloid leukemia.